These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus. Shridhar R, Freilich J, Hoffe SE, Almhanna K, Fulp WJ, Yue B, Karl RC, Meredith K. Ann Surg Oncol; 2014 Nov; 21(12):3744-50. PubMed ID: 24854492 [Abstract] [Full Text] [Related]
9. Resectable esophageal carcinoma: local control with neoadjuvant chemotherapy and radiation therapy. Chidel MA, Rice TW, Adelstein DJ, Kupelian PA, Suh JH, Becker M. Radiology; 1999 Oct 01; 213(1):67-72. PubMed ID: 10540642 [Abstract] [Full Text] [Related]
10. Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer. Tiesi G, Park W, Gunder M, Rubio G, Berger M, Ardalan B, Livingstone A, Franceschi D. J Surg Res; 2017 Aug 01; 216():65-72. PubMed ID: 28807215 [Abstract] [Full Text] [Related]
11. Comparison between definitive chemoradiotherapy and esophagectomy in patients with clinical stage I esophageal squamous cell carcinoma. Yamamoto S, Ishihara R, Motoori M, Kawaguchi Y, Uedo N, Takeuchi Y, Higashino K, Yano M, Nakamura S, Iishi H. Am J Gastroenterol; 2011 Jun 01; 106(6):1048-54. PubMed ID: 21343920 [Abstract] [Full Text] [Related]
12. Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy: results of sequential nonrandomized phase II studies. Algan O, Coia LR, Keller SM, Engstrom PF, Weiner LM, Schultheiss TE, Hanks GE. Int J Radiat Oncol Biol Phys; 1995 Jun 15; 32(3):753-61. PubMed ID: 7790262 [Abstract] [Full Text] [Related]
13. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma. Hsu FM, Lee JM, Huang PM, Lin CC, Hsu CH, Tsai YC, Lee YC, Chia-Hsien Cheng J. Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e593-9. PubMed ID: 21658851 [Abstract] [Full Text] [Related]
14. Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation. Swisher SG, Moughan J, Komaki RU, Ajani JA, Wu TT, Hofstetter WL, Konski AA, Willett CG. J Thorac Oncol; 2017 Feb 15; 12(2):368-374. PubMed ID: 27729298 [Abstract] [Full Text] [Related]
16. Comparison between chemoradiation protocol intended for organ preservation and conventional surgery for clinical T1-T2 esophageal carcinoma. Murakami M, Kuroda Y, Nakajima T, Okamoto Y, Mizowaki T, Kusumi F, Hajiro K, Nishimura S, Matsusue S, Takeda H. Int J Radiat Oncol Biol Phys; 1999 Sep 01; 45(2):277-84. PubMed ID: 10487546 [Abstract] [Full Text] [Related]
18. Concurrent oxaliplatin, 5-fluorouracil, and radiotherapy in the treatment of locally advanced esophageal carcinoma. O'Connor BM, Chadha MK, Pande A, Lombardo JC, Nwogu CE, Nava HR, Yang G, Javle MM. Cancer J; 2007 Sep 01; 13(2):119-24. PubMed ID: 17476140 [Abstract] [Full Text] [Related]
19. Squamous cell carcinoma of the esophagus infiltrating the respiratory tract is less sensitive to preoperative concurrent radiation and chemotherapy. Yano M, Shiozaki H, Tsujinaka T, Inoue M, Doki Y, Fujiwara Y, Monden M. J Am Coll Surg; 2000 Dec 01; 191(6):626-34. PubMed ID: 11129811 [Abstract] [Full Text] [Related]
20. Trimodality treatment versus surgery alone for esophageal cancer. A stratified analysis with minimally invasive pretreatment staging. Jiao X, Sonett J, Gamliel Z, Doyle A, Schuetz J, Greenwald B, Suntharalingam M, Krasna MJ. J Cardiovasc Surg (Torino); 2002 Aug 01; 43(4):531-7. PubMed ID: 12124569 [Abstract] [Full Text] [Related] Page: [Next] [New Search]